Skip to content
DataLookout
Menu

SEMAFORCRANIONCT07845994

SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years

StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Start date pushed from Nov 2026 to Dec 2026
    • Primary and study completion dates: Feb 2031 to Mar 2031
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Change in BMI SD score (according to french references) at 40 weeks
Timeframe: 40 weeks
Change in BMI SD score (according to french references) at 80 weeks
Timeframe: 80 weeks

Secondary (21)

Change in BMI in kg/m at 40 weeks compared between semaglutide and placebo
Change in BMI in kg/m at 80 weeks between compared between semaglutide and placebo
Intra-individual progression of BMI-DS at each visit depending on Semaglutide treatment
Effects of 40 weeks of weekly semaglutide treatment on height
Effects of 40 weeks of weekly semaglutide treatment on weight
Show 16 moreShow less
Effects of 40 weeks of weekly semaglutide treatment on waist circumference
Effects of 40 weeks of weekly semaglutide treatment on arterial blood pressure
Effects of 40 weeks of weekly semaglutide treatment on fasting blood glucose
Effects of 40 weeks of weekly semaglutide treatment on HbA1C
Effects of 40 weeks of weekly semaglutide treatment on insulin level
Effects of 40 weeks of weekly semaglutide treatment on cholesterol
Effects of 40 weeks of weekly semaglutide treatment on triglycerides
Effects of 40 weeks of weekly semaglutide treatment on body composition
Effects of 40 weeks of weekly semaglutide treatment on bone age
Effects of 40 weeks of weekly semaglutide treatment on quality of life by PedsQL questionnaire
Effects of 40 weeks of weekly semaglutide treatment on quality of life by Epworth Sleepiness Scale
Effects of 40 weeks of weekly semaglutide treatment on quality of life by IWQOL-Kids questionnaire
Effects of 40 weeks of weekly semaglutide treatment on quality of life by Dykens Hyperphagia questionnaire
Effects of 40 weeks of weekly semaglutide treatment on quality of life by Daily Hunger Score
Safety between 2 arms
Kinetics of BMI-DS evolution

Arms and interventions

SEMAGLUTIDEExperimental
PLACEBOPlacebo comparator

Drugs: Semaglutide (Wegovy) weekly injection, Placebo weekly Injection

Sites

17 sites in 1 country